Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

67.79 -0.95 (-1.38%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

47 48 Next >

Don't overlook NASDAQ:DXCM—a stock with solid growth prospects and a reasonable valuation. ↗

January 23, 2024

Investors should take note ofDEXCOM INC (NASDAQ:DXCM), a growth stock that remains attractively priced.

Via Chartmill

MarketBeat ‘Stock of the Week’: Intuitive Surgical hits new highs

January 22, 2024

With recent obesity drug fears proving to be overblown and equipment placements growing, expect ISRG to reward growth investors with plenty more record highs.

Via MarketBeat

Topics Earnings

3 Mid-Cap Stocks Poised for a Breakout in 2024 ↗

January 16, 2024

Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.

Via InvestorPlace

The 3 Best Growth Stocks to Buy in January 2024 ↗

January 14, 2024

The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth.

Via InvestorPlace

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review ↗

January 12, 2024

The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.

Via Investor's Business Daily

Topics ETFs

Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

January 10, 2024

Via Benzinga

2 Growth Stocks That Could Make You Richer in 2024 and Beyond ↗

January 09, 2024

Last year wasn't great for either stock, but that's no reason to ignore them.

Via The Motley Fool

History Says the Nasdaq Will Soar in 2024: 1 Stock-Split AI Growth Stock to Buy Now and Hold Forever ↗

January 09, 2024

Nvidia is well positioned to create value for patient shareholders, given its leadership in artificial intelligence chips.

Via The Motley Fool

Topics Artificial Intelligence

3 Stocks to Capitalize on the Telehealth Explosion ↗

January 08, 2024

These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.

Via InvestorPlace

Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales ↗

January 08, 2024

Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance.

Via Investor's Business Daily

A Closer Look at DexCom's Options Market Dynamics ↗

January 08, 2024

Via Benzinga

Is NASDAQ:DXCM a Fit for Growth Investing Strategies? ↗

January 04, 2024

Should you consider DEXCOM INC (NASDAQ:DXCM) for growth investing?

Via Chartmill

The Latest Analyst Ratings For DexCom ↗

January 03, 2024

Via Benzinga

DexCom Unusual Options Activity ↗

January 02, 2024

Via Benzinga

Looking Into DexCom's Recent Short Interest ↗

December 22, 2023

Via Benzinga

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook

January 08, 2024

From DexCom, Inc.

Via Business Wire

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Via MarketBeat

Topics ETFs

Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

January 03, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.

Via Chartmill

1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid ↗

January 03, 2024

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an...

Via The Motley Fool

$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today ↗

December 21, 2023

Via Benzinga

DexCom's Options Frenzy: What You Need to Know ↗

December 20, 2023

Via Benzinga

For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering. ↗

January 02, 2024

NASDAQ:DXCM stands out as a growth opportunity that won't break the bank.

Via Chartmill

These 3 Companies Can Be the Next Stock-Split Stocks in 2024 ↗

December 29, 2023

Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in...

Via The Motley Fool

Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024 ↗

December 27, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha.

Via The Motley Fool

3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024 ↗

December 25, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for...

Via The Motley Fool

DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations ↗

December 13, 2023

DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

December 12, 2023

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 19, 2023

From DexCom, Inc.

Via Business Wire

3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts ↗

December 18, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the...

Via The Motley Fool

Pet Parents Keep Spending ↗

December 13, 2023

We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care.

Via The Motley Fool

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.